REGN: Regeneron Pharmaceuticals Inc. Stocks News on July 26, 2024

REGN

Simply Wall St.

12 hours ago

Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

REGN

Zacks

a day ago

Regeneron (REGN) Earnings Expected to Grow: Should You Buy?

Trials to watch: Four biologics concluding pivotal COPD trials

REGN

Clinical Trials Arena

2 days ago

Trials to watch: Four biologics concluding pivotal COPD trials

REGN

Investing.com

2 days ago

Sanofi lifts FY guidance after strong Q2 results

REGN

Zacks

2 days ago

Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?

REGN

MT Newswires

4 days ago

TD Cowen Adjusts Price Target on Regeneron Pharmaceuticals to $1,200 From $1,030, Maintains Buy Rating

REGN

Zacks

4 days ago

HRMY or REGN: Which Is the Better Value Stock Right Now?

REGN

MT Newswires

4 days ago

Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $1,235 From $1,135

REGN

MT Newswires

4 days ago

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $1,000 From $925

REGN

MT Newswires

7 days ago

Piper Sandler Raises Price Target on Regeneron Pharmaceuticals to $1,166 From $1,000, Overweight Rating Maintained

REGN

MT Newswires

7 days ago

--BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $1,300 From $1,082, Outperform Rating Maintained

REGN

MT Newswires

9 days ago

Guggenheim Adjusts Price Target on Regeneron Pharmaceuticals to $1,180 From $1,040, Maintains Buy Rating

REGN

Simply Wall St.

12 days ago

Regeneron Pharmaceuticals (NASDAQ:REGN) stock performs better than its underlying earnings growth over last five years

REGN

MT Newswires

14 days ago

UBS Raises Price Target on Regeneron Pharmaceuticals to $1,250 From $1,124, Maintains Buy Rating

REGN

MT Newswires

15 days ago

Morgan Stanley Trims Price Target on Regeneron Pharmaceuticals to $1,182 From $1,183

REGN

MT Newswires

16 days ago

Barclays Adjusts Price Target on Regeneron Pharmaceuticals to $1,200 From $1,050

REGN

MT Newswires

18 days ago

RBC Lifts Price Target on Regeneron Pharmaceuticals to $1,232 From $1,229, Keeps Outperform Rating

REGN

Motley Fool

18 days ago

3 No-Brainer Stocks to Buy in July

Swing Trading Regeneron Stock Shows How To Bob And Weave

REGN

Investor's Business Daily

21 days ago

Swing Trading Regeneron Stock Shows How To Bob And Weave

Dupixent “addresses current gap” in COPD biologics landscape

REGN

Pharmaceutical Technology

21 days ago

Dupixent “addresses current gap” in COPD biologics landscape

Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data

REGN

Benzinga

23 days ago

Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data

REGN

Zacks

23 days ago

Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD

REGN

MT Newswires

24 days ago

Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

REGN

GlobeNewswire

24 days ago

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

REGN

GuruFocus.com

24 days ago

Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)

REGN

MT Newswires

24 days ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,190,564, According to a Recent SEC Filing

Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness

REGN

Simply Wall St.

24 days ago

Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness

REGN

Zacks

25 days ago

Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug

REGN

MT Newswires

a month ago

Regeneron Gets European Health Agency Committee's Positive Opinion for Conditional Marketing Authorization of Lymphoma Drug Candidate Odronextamab

What's Going On With Regeneron Pharmaceuticals Stock On Friday?

REGN

Benzinga

a month ago

What's Going On With Regeneron Pharmaceuticals Stock On Friday?

$Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma$

REGN

GlobeNewswire

a month ago

Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

REGN

GlobeNewswire

a month ago

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

REGN

MT Newswires

a month ago

Regeneron, Sanofi Eosinophilic Esophagitis Treatment Showed Improvements for Children in Phase 3 Study

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

REGN

GlobeNewswire

a month ago

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

REGN

Simply Wall St.

a month ago

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Could Be 45% Below Their Intrinsic Value Estimate

REGN

MT Newswires

a month ago

Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,170 From $1,060, Buy Rating Maintained

REGN

Argus Research

a month ago

Analyst Report: Regeneron Phars, Inc

REGN

Argus Research

a month ago

Technical Assessment: Bullish in the Intermediate-Term

REGN

Argus Research

a month ago

Market Digest: DRI, KMX, OXY, REGN

Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion

REGN

Clinical Trials Arena

a month ago

Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion

REGN

TipRanks

a month ago

Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?

REGN

Zacks

a month ago

Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing

Regeneron touts success with bispecific antibody in multiple myeloma trial

REGN

Clinical Trials Arena

a month ago

Regeneron touts success with bispecific antibody in multiple myeloma trial

EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma

REGN

Clinical Trials Arena

a month ago

EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma

REGN

Clinical Trials Arena

a month ago

EHA2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma

REGN

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Regeneron Pharmaceuticals to $1,150 From $1,050

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals Says 50% of Patients in Multiple Myeloma Therapy Study Achieved Complete Response

Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma

REGN

GlobeNewswire

a month ago

Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma

REGN

Morningstar Research

a month ago

Analyst Report: Regeneron Pharmaceuticals, Inc.

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea

REGN

Simply Wall St.

a month ago

Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $25,610,229, According to a Recent SEC Filing

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

REGN

Investor's Business Daily

a month ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

REGN

TipRanks

a month ago

REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club

REGN

Investor's Business Daily

a month ago

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club

REGN

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on Regeneron Pharmaceuticals to $1,125 From $1,050

REGN

MT Newswires

a month ago

RBC Capital Raises Price Target on Regeneron Pharmaceuticals to $1,229 From $1,200, Maintains Outperform Rating

REGN

Zacks

a month ago

Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion

REGN

MT Newswires

2 months ago

Regeneron, Sanofi Gain FDA Approval for Kevzara to Treat Juvenile Idiopathic Arthritis

Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

REGN

GlobeNewswire

2 months ago

Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $798,821, According to a Recent SEC Filing

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

REGN

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

REGN

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

REGN

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

REGN

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

REGN

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

REGN

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

REGN

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

REGN

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

REGN

Simply Wall St.

2 months ago

Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health?

Stock Split Watch: 3 Growth Stocks That Could Be Next

REGN

Motley Fool

2 months ago

Stock Split Watch: 3 Growth Stocks That Could Be Next

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing

Health Care Stocks Show Relative Strength as S&P 500 Stalls

REGN

Zacks

2 months ago

Health Care Stocks Show Relative Strength as S&P 500 Stalls

REGN

Argus Research

2 months ago

Technical Assessment: Bullish in the Intermediate-Term

REGN

MT Newswires

2 months ago

RBC Adjusts Price Target on Regeneron Pharmaceuticals to $1,200 From $1,185

REGN

MT Newswires

2 months ago

FibroGen Investigational New Drug Application for Cancer Treatment Accepted by FDA; Regeneron Selected as Supplier

REGN

Insider Monkey

2 months ago

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?

FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease

REGN

Benzinga

2 months ago

FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease

FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD

REGN

Zacks

2 months ago

FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD

REGN

MT Newswires

2 months ago

Sanofi, Regeneron's Dupixent Receives Recommendation for Approval From European Medicines Agency Committee

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD

REGN

GlobeNewswire

2 months ago

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD

Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation

REGN

GlobeNewswire

2 months ago

Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation

Biohaven doses first subject in Phase I/II tumour treatment study

REGN

Clinical Trials Arena

2 months ago

Biohaven doses first subject in Phase I/II tumour treatment study

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,142,536, According to a Recent SEC Filing

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors

REGN

PR Newswire

2 months ago

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution

REGN

Simply Wall St.

2 months ago

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution

The Biggest Biotechnology Company in Europe

REGN

Insider Monkey

2 months ago

The Biggest Biotechnology Company in Europe

The Biggest Publicly Traded Biotech Company

REGN

Insider Monkey

2 months ago

The Biggest Publicly Traded Biotech Company

REGN

Motley Fool

2 months ago

2 Biotech Stocks to Buy in May

Ireland – the jewel in the life sciences crown?

REGN

Medical Device Network

2 months ago

Ireland – the jewel in the life sciences crown?

REGN

Zacks

2 months ago

Regeneron (REGN) Announces Positive Data on Oncology Candidate

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals Says GN7075 Plus Libtayo Shows Anti-Tumor Responses in Microsatellite Stable Colorectal Cancer

REGN

GlobeNewswire

2 months ago

Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO

3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

REGN

Motley Fool

2 months ago

3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

REGN

MT Newswires

2 months ago

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing

REGN

Simply Wall St.

2 months ago

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?

Regeneron faces new biosimilar threats; an AI biotech lays off staff

REGN

BioPharma Dive

2 months ago

Regeneron faces new biosimilar threats; an AI biotech lays off staff

REGN

MT Newswires

2 months ago

Latest Regeneron Pharmaceuticals Inc. (REGN) News on July 26, 2024

Share on Social Networks: